HER2+ (Positive) Breast Cancer
Archives for July 2017
Discussion List
-
Nerlynx Approved by FDA to Treat Early-Stage, HER2-Positive BC
Nerlynx Approved by FDA to Treat Early-Stage, HER2-Positive Breast Cancer July 18, 2017 Nerlynx was approved by the FDA on July 17, 2017 to treat early-stage, HER2-positive breast cancer for an extended period after surgery in people who have previously been treated with Herceptin. Read more...
Join Us on Zoom: Upcoming virtual meetups. Read more...